Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
Lupin Pharmaceuticals Inc.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Lupin Pharmaceuticals Inc.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Dr. Reddy's Laboratories, Inc.
Failed Impurities/Degradation Specification
Dr. Reddy's Laboratories, Inc.
Failed Impurities/Degradation Specification
BLI International, Inc.
Superpotent Drug: Stability failure for assay at 6 months test time-point.
AvKARE
Labeling: Label Mix-Up
AvKARE
Labeling: Label Mix-Up
Elavil
Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…
Keystone Industries
Subpotent Drug
Apo-Amitriptyline
Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…
Akron Pharma, Inc.
CGMP Deviations
Jamp-Finasteride 5 mg tablet
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Padagis US LLC
Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
Stress-B-Plus Tablet
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Breckenridge Pharmaceutical, Inc
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
ACCORD HEALTHCARE, INC.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
ACCORD HEALTHCARE, INC.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
ACCORD HEALTHCARE, INC.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Dr. Reddy's Laboratories, Inc.
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Dr. Reddy's Laboratories, Inc.
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Dr. Reddy's Laboratories, Inc.
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
C & A Naturistics
Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
Neogen Corporation
CGMP violations.
Neogen Corporation
CGMP violations.
Love Bites & Spanish Fly male / female sensual gummies
Unauthorized product. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any heal…